Ovid Financial Statements From 2010 to 2025

Ovid Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 100.8 M 92.2 M 70.5 M Slightly volatile Other Current Liabilities 6 M 6 M 4.1 M Slightly volatile Total Current Liabilities 9.7 M 10.5 M 6.7 M Slightly volatile Total Stockholder Equity 82.6 M 68.2 M 58 M Slightly volatile Net Tangible Assets 81.7 M 152.1 M 65.8 M Slightly volatile Property Plant And Equipment Net 13.9 M 13.2 M 3.7 M Slightly volatile Accounts Payable 3.2 M 3.2 M 2.2 M Slightly volatile Cash 25 M 26.3 M 43.4 M Slightly volatile Non Current Assets Total 38 M 36.2 M 9 M Slightly volatile Non Currrent Assets Other 1.1 M 1.9 M 770.8 K Slightly volatile Cash And Short Term Investments 88 M 53.1 M 61.7 M Slightly volatile Common Stock Shares Outstanding 46.6 M 70.9 M 33.2 M Slightly volatile Liabilities And Stockholders Equity 100.8 M 92.2 M 70.5 M Slightly volatile Other Current Assets 2.1 M 2.9 M 1.5 M Slightly volatile Other Stockholder Equity 261.5 M 372.5 M 181.1 M Slightly volatile Total Liabilities 18.2 M 23.9 M 12.5 M Slightly volatile Total Current Assets 90.2 M 55.9 M 63.3 M Slightly volatile Intangible Assets 87.4 K 92 K 138.1 K Slightly volatile Common Stock 51.3 K 81.7 K 41 K Slightly volatile Property Plant Equipment 1.4 M 1.3 M 353.2 K Slightly volatile Net Receivables 403.4 K 300.4 K 270 K Slightly volatile Common Stock Total Equity 46.7 K 81 K 36.7 K Slightly volatile Property Plant And Equipment Gross 15.4 M 14.6 M 4 M Slightly volatile Capital Surpluse 312.6 M 411.4 M 254.8 M Slightly volatile Net Invested Capital 96.8 M 68.2 M 86.5 M Pretty Stable Net Working Capital 43.1 M 45.4 M 81.5 M Very volatile Capital Stock 67.2 K 71 K 43.3 K Slightly volatile Other Liabilities 12.4 M 11.8 M 4.2 M Slightly volatile Non Current Liabilities Other 36.2 M 34.5 M 10.2 M Slightly volatile Current Deferred Revenue 1.8 M 2 M 2.2 M Slightly volatile Short and Long Term Debt Total 12.6 M 14.8 M 16.1 M Slightly volatile Short Term Debt 1.1 M 1.3 M 666.6 K Slightly volatile
Ovid Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 365.4 K 613 K 251.8 K Slightly volatile Selling General Administrative 22.9 M 25.7 M 15.8 M Slightly volatile Other Operating Expenses 57.3 M 62.5 M 39.5 M Slightly volatile Research Development 34.3 M 36.8 M 23.6 M Slightly volatile Total Operating Expenses 57.3 M 62.5 M 39.5 M Slightly volatile Interest Income 4.1 M 3.9 M 1.9 M Slightly volatile Net Interest Income 2 M 3.9 M 1.8 M Slightly volatile Reconciled Depreciation 639.5 K 613 K 365.8 K Slightly volatile Non Operating Income Net Other 957.3 K 1.6 M 723.3 K Slightly volatile Selling And Marketing Expenses 581 653 712 Slightly volatile
Ovid Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Sale Purchase Of Stock 154.5 K 162.6 K 20.2 M Very volatile Net Borrowings 64 K 72 K 78.5 K Slightly volatile Stock Based Compensation 5.6 M 6.3 M 3.9 M Slightly volatile Depreciation 468.3 K 613 K 322.5 K Slightly volatile Capital Expenditures 67.5 K 71 K 197.9 K Slightly volatile End Period Cash Flow 26.8 M 28.2 M 44.4 M Slightly volatile Change To Netincome 8.9 M 7.5 M 6 M Slightly volatile Begin Period Cash Flow 27.5 M 29 M 42.6 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 127 117 64.4051 Slightly volatile PTB Ratio 0.92 0.9704 5.3599 Slightly volatile Days Sales Outstanding 3.28 3.69 4.0241 Slightly volatile Book Value Per Share 0.91 0.9622 1.6907 Very volatile Average Payables 2.1 M 3.2 M 2.3 M Slightly volatile Stock Based Compensation To Revenue 11.64 11.0883 3.2672 Slightly volatile Capex To Depreciation 0.11 0.1158 1.2137 Pretty Stable PB Ratio 0.92 0.9704 5.3599 Slightly volatile EV To Sales 116 96.5689 55.4684 Slightly volatile Payables Turnover 0.67 0.64 0.2776 Slightly volatile Sales General And Administrative To Revenue 23.82 45.3763 12.3137 Slightly volatile Average Inventory 97.1 K 109.2 K 119.1 K Slightly volatile Research And Ddevelopement To Revenue 68.21 64.9594 17.378 Slightly volatile Capex To Revenue 0.23 0.1254 0.1245 Slightly volatile Cash Per Share 0.71 0.7485 1.7667 Very volatile Days Payables Outstanding 563 593 10 K Slightly volatile Income Quality 2.22 2.1169 0.8859 Slightly volatile Intangibles To Total Assets 9.0E-4 0.001 0.0019 Pretty Stable Current Ratio 5.05 5.3165 20.5509 Slightly volatile Tangible Book Value Per Share 0.91 0.9609 1.687 Very volatile Receivables Turnover 71.2 80.1 87.3318 Slightly volatile Shareholders Equity Per Share 0.91 0.9622 1.6907 Very volatile Debt To Equity 0.14 0.2163 0.1352 Slightly volatile Capex Per Share 0.001 0.001 0.0044 Slightly volatile Graham Net Net 0.39 0.4109 1.5228 Pretty Stable Average Receivables 60.6 K 63.8 K 142.2 K Pretty Stable Revenue Per Share 0.0076 0.008 0.3441 Very volatile Interest Debt Per Share 0.24 0.2081 0.2329 Slightly volatile Debt To Assets 0.1 0.1601 0.1097 Slightly volatile Graham Number 8.36 9.4 10.2495 Slightly volatile Operating Cycle 3.28 3.69 4.0241 Slightly volatile Price Book Value Ratio 0.92 0.9704 5.3599 Slightly volatile Days Of Payables Outstanding 563 593 10 K Slightly volatile Ebt Per Ebit 0.41 0.4271 0.9147 Slightly volatile Effective Tax Rate 0.0064 0.0096 0.0063 Slightly volatile Company Equity Multiplier 0.98 1.3509 1.1662 Slightly volatile Total Debt To Capitalization 0.12 0.1778 0.1185 Slightly volatile Debt Equity Ratio 0.14 0.2163 0.1352 Slightly volatile Quick Ratio 5.05 5.3165 20.5468 Slightly volatile Net Income Per E B T 0.79 0.89 0.9706 Slightly volatile Cash Ratio 2.37 2.4996 18.6508 Slightly volatile Days Of Sales Outstanding 3.28 3.69 4.0241 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.11 1.0013 1.0134 Slightly volatile Price To Book Ratio 0.92 0.9704 5.3599 Slightly volatile Fixed Asset Turnover 0.0406 0.0428 118 Very volatile Debt Ratio 0.1 0.1601 0.1097 Slightly volatile Price Sales Ratio 127 117 64.4051 Slightly volatile Asset Turnover 0.0058 0.0061 0.1827 Very volatile Gross Profit Margin 0.8 0.9 0.9812 Slightly volatile Price Fair Value 0.92 0.9704 5.3599 Slightly volatile
Ovid Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 141.4 M 76.1 M 133.9 M Slightly volatile Enterprise Value 87.2 M 62.9 M 81.8 M Slightly volatile

Ovid Fundamental Market Drivers

Ovid Upcoming Events

About Ovid Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ovid Therapeutics is a strong investment it is important to analyze Ovid Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ovid Therapeutics' future performance. For an informed investment choice regarding Ovid Stock, refer to the following important reports:

How To Invest In Ovid Details

Is Ovid Stock a good investment? Details

What is Ovid Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details